| Literature DB >> 31008062 |
A Edobor-Osoh1, P de la Presa2, B I Ita3, K O Ajanaku1, F E Owolabi1, S J Olorunshola4.
Abstract
We report the structural, morphological and optical activities of a paramagnetic manganite (La0.33Ca0.67MnO3) synthesized at 900 °C. A simple method of formation of complex was employed. A complex was formed between a pre-prepared manganite dissolved in HCl and reacted with an organic ligand (ethyl 4-nitrobenzoate). The optical and antimicrobial properties of a complex were determined. The Ultraviolet-visible and Fourier-transform infra-red spectroscopy were used in monitoring optical activities of the resulting product. It was observed to absorb in the visible region (205 nm and 256 nm). The peaks observed from the infra-red spectra indicated that the reaction occurred at the nitroso end of the ethyl 4-nitrobenzoate. The bacterial inhibitory property of the LCMO-ethyl 4-nitrobenzoate was determined against Pseudomonas aeruginosa, Candida albican, Aspergillus niger and Staphylococcus auerus. It was observed to inhibit the growth of all the microbes with zone of inhibitions of 60 mm, 56 mm, 45 mm and 32 mm, for Pseudomonas aeruginosa, Candida albican, Aspergillus niger and Staphylococcus auerus, respectively. •The method used was simple and a complex was formed within 6 h without the use of complicated equipment.•The method requires no heat treatment and can be prepared at room temperature.•LCMO-ethyl 4-nitrobenzoate was biologically active against Pseudomonas aeruginosa, Candida albican, Aspergillus niger and Staphylococcus aureus.Entities:
Keywords: Antimicrobial agent; Ethyl 4-nitrobenzoate; Functionalization; Functionalization of manganite; Manganite; Nanoparticles
Year: 2019 PMID: 31008062 PMCID: PMC6454126 DOI: 10.1016/j.mex.2019.03.004
Source DB: PubMed Journal: MethodsX ISSN: 2215-0161
Fig. 1SEM micrograph of LCMO 900.
Fig. 2XRD Pattern of La0.33Ca0.67MnO3 oxide annealed at 900 oC.
Fig. 3FT-IR image of the LCMO-Ethyl 4-nitrobenzoate complex showing the peak.
The Infra-red peaks observed for the complex formed and the organic ligand (ethyl 4-nitrobenzoate).
| Functional Groups | Range (cm−1) | Range (cm−1) |
|---|---|---|
| C2H5COO (Ester) | 1714.50 | 1712.00 |
| Ar—C | 1603.65 | 1607.00 |
| Ar—N | 1526.15 | 1527.00 |
| Mn—O | 476.63 | – |
Comparison of the ultraviolet-visible wavelength (nm) of ethyl 4-nitrobenzoate and LCMO-ethyl 4-nitrobenzoate.
| S/N | Name of Sample | Wavelength (nm) ( | |
|---|---|---|---|
| Ethyl 4-nitrobenzoate | 256 (5.065) | 202 (4.512) | |
| LCMO + Ethyl 4-nitrobenzoate | 256 (5.421) | 205 (4.972) | |
The zone of inhibition of the La0.33Ca0.67MnO3 –ethyl 4-nitrobenzoate (complex), controls anti-fungal (nitrofuratoin) and anti-bacterial (gentamicin).
| Sample | Concentration | ||||
|---|---|---|---|---|---|
| La0.33Ca0.67MnO3 – Ethyl 4-nitrobenzoate (Complex) | 1000 mg/mL | 32 | 45 | 60 | 56 |
| Nitrofuratoin (control) | 300 μg/mL | – | 32 | – | 28 |
| Gentamicin (control) | 10 μg/disc | 25 | – | 24 | – |
The minimum inhibitory concentration of the La0.33Ca0.67MnO3 – ethyl 4-nitrobenzoate (complex).
| Micro-organism | Minimum inhibitory concentration (mg/mL) |
|---|---|
| 31.25 | |
| 7.80 | |
| 7.81 |
| Materials Science | |
| Biomedical nanoparticles | |
| Functionalization of manganite | |
| 1. Giri, A., Makhal, A., Ghosh, B., Ravchaudhuri, A. K. and Pal, S. K. (2014) Functionalization of manganite nanoparticles and their interaction with biologically relevant small ligand: Picosecond time-resolved FRET studies. Nanoscale, 2, 2704-2709 | |
| NA |